Prospective Data Collection Initiative on Colorectal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colorectal Cancer
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Objectives To start a prospective observational cohort study of CRC patients from their primary diagnosis until death. After obtaining Informed Consent, to prospectively collect data on medical history, serious comorbidities, baseline clinical parameters, imaging results, pathology results, tumor ch...
Objectives To start a prospective observational cohort study of CRC patients from their primary diagnosis until death. After obtaining Informed Consent, to prospectively collect data on medical history, serious comorbidities, baseline clinical parameters, imaging results, pathology results, tumor characteristics, treatment, treatment outcomes, hospital stays, interventions and grade 3/4 adverse events. After obtaining separate Informed Consent for biobanking, to store blood and tumor tissue material, obtained during routine practice, in the biobank. The cohort will serve as an infrastructure geared towards efficient, safe and comprehensive clinical evaluation of new (image guided) interventions for treatment of CRC. Expected outcome More accurate data on the treatment and clinical and patient reported outcomes of CRC in daily practice. A continuous infrastructure for a large variety of research purposes including: A. Prognostic research B. Biological research and (epi)genetic research C. Studies that compare new therapies in a target population according to the cohort multiple randomized controlled trial design. D. Health care policies and cost-effectiveness studies
Tracking Information
- NCT #
- NCT02070146
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Miriam Koopman, MD, PhD UMC Utrecht Principal Investigator: Lenny HM Verkooijen, MD, PhD UMC Utrecht Principal Investigator: Martijn GH van Oijen, PhD Amsterdam UMC Principal Investigator: Peter D Siersema, MD, PhD Radboud University